Position:
Professor
Division:
Endocrinology
Education:
BA Linfield College, McMinnville, Oregon, USA Premedical Sciences & English Literature
MD Boston University School of Medicine, Boston, USA
Recent Publications:
  • Battistella, E, Kalyan S, Prior J.C (2010) Evaluation of successful methods and costs associated with recruiting 600 healthy women volunteers to a study of ovulation. Journal of Women’s Health; 19(8):1519-1524. .
  • Bedford J, Prior J.C, Barr S. (2010) A prospective exploration of cognitive dietary restraint, subclinical ovulatory disturbances, cortisol and change in bone density over two years in healthy young women. Journal of Clinical Endocrinology and Metabolism 95(7):3291-9.
  • Bedford JL, Prior JC, and Barr SI.  A Prospective Exploration of Cognitive Dietary Restraint, Subclinical Ovulatory Disturbances, Cortisol, and Change in Bone Density over Two Years in Healthy Young Women.  J. Clin. Endocrinol. Metab., Rapid Electronic Publication first published on Apr 28, 2010 as doi:doi:10.1210/jc.2009-2497.
  • Berger C, Goltzman D, Langsetmo L, Joseph L, Jackson S, Kreiger N, Tenenhouse A, Davison K.S, Josse R.G, Prior J.C, Hanley D.A; CaMos Research Group (2010). Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. Journal of Bone Mineral Research, 25(9):1948-57.
  • Kalyan S, Hitchcock C. L, Pudek M, & Prior J. C (2010). Acute effects of premenopausal hysterectomy with bilateral oophorectomy on serum lipids, hormonal values, inflammatory markers and metabolism. Journal of Gynecologic Surgery, In Press (accepted March 8, 2010).
  • Kalyan S, Hitchcock C.L, Sirrs S, Pudek M, Prior J.C (2010) Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen: A one-year randomized double-blind trial following premenopausal hysterectomy with bilateral ovariectomy. Pharmacotherapy. 2010; 30(5):442–452.
  • Kalyan S, Prior J.C (2010). Bone Changes and Fracture Related to Menstrual Cycles. Crit Rev Eukaryot Gene Expr.20(3):213-33.
  • Kalyan S., Hitchcock C.L., Sirrs S., Pudek M., Prior J.C. (2010) Cardiovascular and Metabolic Effects of Medroxyprogesterone Acetate versus Conjugated Equine Estrogen After Premenopausal Hysterectomy with Bilateral Ovariectomy.  Pharmacotherapy, 30(5): 442-452.
  • Kingwell E, Prior J.C, Ratner PA, Kennedy SM, (2010) Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians, Osteoporosis Int. 21(2):307-19.
  • Kingwell E., Prior J.C., Ratner P.A., Kennedy S.M. (2010). Direct-to-Participant Feedback and Awareness of Bone Mineral Density Testing Results in a Population-Based Sample of Mid-Aged Canadians. Osteoporosis International, 2010;21(2):307-19.
  • Langsetmo L, Leslie W.D, Zhou W, Goltzman D, Kovacs C.S, Prior J, Josse R, Olszynski W.P, Davison K.S, Anastassiades T, Towheed T, Hanley D.A, Kaiser S, Kreiger N; CaMOS Research Group (2010). Using the same bone density reference database for men and women provides a simpler estimation of fracture risk. Journal of Bone Mineral Research 25(10):2108-14.
  • Langsetmo L, Morin S, Kovacs C.S, Kreiger N, Josse R, Adachi J.D, Papaioannou A, Goltzman D, Hanley DA, Olszynski W.P, Prior J, Jamal S.A; CaMos Research Group (2010). Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture risk. Menopause 17(5):1010-6.
  • Langsetmo L, Poliquin S, Hanley D.A., Prior J.C, Barr S., Anastassiades T., Towheed T, Goltzman D, Kreiger N. (2010) Dietary patterns in Canadian Men and Women Ages 25 and Older: Relationship to Demographics, Body Mass Index and Bone Mineral Density, BMC- Musculoskelet Disord; 11:20-26. .
  • Marks M., Hitchcock C.L., Sathi P., Prior J.C. (2010) Community pharmacists’ therapeutic recommendations for heavy flow, androgen excess, fragility fractures and night sweats in menstruating women. Canadian Pharmacists Journal, 143(2): 88-95 e.2.
  • Prior J.C, Hitchcock C. L. (2010) The endocrinology of perimenopause: need for a paradigm shift. Frontiers in Bioscience (Scholastic ed.) 3:474-86. .
  • Zhou W, Langsetmo L, Berger C, Adachi J.D, Papaioannou A, Ioannidis G, Webber C, Atkinson S.A, Olszynski W.P, Brown J.P, Hanley D.A, Josse R, Kreiger N, Prior J.C, Kaiser S, Kirkland S, Goltzman D. and Davison K.S, the CaMos Research Group (2010). Normative bone mineral density Z-Scores for Canadians aged 16-24 yr: the Canadian Multicentre Osteoporosis Study. Journal of Clinical Densitometry 13(3):267-7.
  • Langsetmo L, Nguyen T.V, Nguyen N.D, Kovacs C.S, Prior J.C, Center J.R, Morin S, Josse R.G, Adachi J.D, Hanley D.A, Eisman J.A. and the CaMos Research Group (2010). Independent External Validation of Nomograms for Low Trauma Fracture and Hip Fracture Risk in a Population of Canadian Men and Women Ages 55-95. Canadian Medical Association Journal In Press (accepted Aug 2010).
  • Seifert-Klauss V and Prior J.C (2010). Progesterone and Bone – Actions Promoting Bone Health in Women. Journal of Osteoporosis Oct 31;2010:845180.
  • Bedford J.L., Prior J.C., Hitchcock C.L., & Barr S.I. (2009). Detecting evidence of luteal activity by least-squares quantitative basal temperature analysis against urinary progesterone metabolites and the effect of wake-time variability. European Journal of Obstetrics and Gynecology and Reproductive Biology, 146:76-80.
  • Berger, C., Langsetmo, L., Joseph, L., Hanley, D.A., Davison, S.K., Josse, R.G., Prior, J.C., Krieger, N., Tenenhouse, A., Goltzman, D., and the CaMos Research Group (2009). Association Between Change in BMD and Fragility Fracture in Women and Men. JBMR, 24(2): 361-371.
  • Chen P., Krege J.H., Adachi J.D., Prior J.C., Tenenhouse A., Brown J.P., Papadimitropoulos M., Kreiger N., Olszynski W.P., Josse R.G., Goltzman D., Vertebral Fracture Status and the World Health Organization (WHO)Risk Factors for Predicting Osteoporotic Fracture Risk. Journal of Bone Mineral Research, 2009, 24(3): 495-502.
  • Harvey A.T., Hitchcock C.L., Prior J.C. (2009). Ovulation disturbances and mood across the menstrual cycles of healthy women. Journal of Psychosomatic Obstetrics and Gynecology, 30(4), 207-214.
  • Ioannidis G., Papaioannou A., Hopman W.M., Akhatar-Danesh N., Anastassiades T., Pickard L., Kennedy C.C., Prior J.C.,  Olszynski W.P., Davison K.S., Goltzman D., Thabane L., Gafni A., Papadimitriopoulos E.A., Brown J.P., Josse R.G., Hanley D.A., Adachi J.D.(2009) Relationship between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. Canadian Medical Association Journal, 181: 265-271.
  • Jamal S.A., Swan V.J., Brown J.P., Hanley D.A., Prior J.C., Papaioannou A., Langsetmo L., Josse R.G., Canadian Multicentre Osteoporosis Study Research Group. (2009) Kidney Function and Rate of Bone Loss at the Hip and Spine: The Canadian Multicentre Osteoporosis Study. American Journal of Kidney Function, 55(2) 291-299.
  • Langsetmo L., Goltzman D., Kovacs C.S., Adachi J.D., Hanley D.A., Kreiger N., Josse R., Papaionnou A., Olszynski W.P., Jamal SA., CaMOS Research Group. Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. (2009) Journal of Bone and Mineral Research, (9):1515-22.
  • Langsetmo L.A, Morin, S., Richards, J.B., Davison, K.S., Olszynski W.P, Prior, J.C., Josse, R., Goltzman, D., & CaMos Research Group (2009). Effectiveness of antiresorptives for the prevention of non-vertebral low-trauma fractures in a population-based cohort of women. Osteoporosis International, 20:283–290.
  • Papaioannou A, Kennedy C.C., Ioanidis G., Sawka A., Hopman W.M., Pickard L., Brown J.P., Josse R.G., Kaiser S., Anastassiades T., Goltzman D., Papadimirtopoulous M., Tenenhouse A., Prior J.C., Olszynski W.P., Adachi J.D., for the CaMos Study Group. The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporosis International 2009, 20:703-714.
  • Harris A, Prior J, Koehoorn M. Age at Menarche in the Canadian Population: Secular Trends and Relationship to Adulthood BMI. Journal of Adolescent Health 2008, 43(5): 466-473.
  • Jamal SA, Goltzman D, Hanley DA, Papaioannou D, Prior JC, Josse RG.  Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study. Osteoporosis International, 2008, 20, (5): 737-741.
  • Langsetmo, L., Hanley, D. A., Kreiger, N., Jamal, S. A., Prior, J. C., Adachi, J. D., Davison, K. S., Kovacs, C., Anastassiades, T., Tenenhouse, A., Goltzman, D., & CaMos Research Group. (2008). Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older. Bone, 43 (4): 672-678.
  • Papaioannou A, Kennedy CC, Ioannidis G, Gao Y, Sawka AM, Goltzman D, Tenenhouse A, Pickard L, Olszynski WP, Davison KS, Kaiser S, Josse RG, Kreiger N, Hanley DA, Prior JC, Brown JP, Anastassiades T, Adachi JD, CaMos Research Group. The osteoporosis care gap in men with fragility fractures: The Canadian Multicentre Osteoporosis Study. Osteoporosis International 2008; 19(4): 581-587.
  • Hopman WM, Lawrence J, Berger C, Poliquin S, Barr S,  Prior JC, Anastassiades T, Towheed T. The Association Between Body Mass Index and Health-Related Quality of Life: Data from CaMos, a Stratified Population Study. Quality of Life Research.2007.16 (10) :1595-1603.
  • Hopman WM, Leroux C, Berger C, Joseph L, Barr  SI, Prior JC, Harrison M, Poliquin S, Towheed T, Anastassiades T, Goltzman D, CaMos Research Group. Changes in Body mass index in Canadians over a five-year period: Results of a prospective, population based study.  BMC Public Health 2007;7:150.
  • Prior JC, Burdge D, Maan E. Fragility Fractures and Bone Mineral Density in HIV Positive Women: a case-control population based study. Osteoporosis International 2007:18 (10).1345-1353.
  • Prior JC, Nielson JD, Hitchcock CL, Williams LA, Vigna YM, Dean CB. Medroxyprogesterone and conjugated estrogen are equivalent for hot flushes–a one-year randomized double blind trial following premenopausal ovariectomy. Clinical Science. 2007;112(10); 517-525. .
  • Richards J B, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior J C, Goltzman D, for the Canadian Multicentre Osteoporosis Study (CaMos) Research Group. Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture.  Archives of Internal Medicine. 2007:167:188-194.
  • Richards JB, Leslie WD, Joseph L, Siminoski K, Hanley DA, Adachi JD, Brown JP, Morin S, Papaioannou A, Josse RG, Prior JC, Davison KS, Tenenhouse A, Goltzman D, and for the CaMos Research Group. Changes to Osteoporosis Prevalence According to Method of Risk Assessment. Journal of Bone Mineral Research 2007;  22: 228-2354.
  • Hopman WM, Berger C, Joseph L, VandenKerkhof E, Anastassiades T, Adachi JD, Ioannidis G, Brown JP, Hanley DA, Papadimitropoulos EA, Tenenhouse A, CaMOS Research Group. The natural progression of health-related quality of life: results of a five-year prospective study of SF-36 scores in a normative population. Quality Life Research. 2006; 15(3): 527-36.
  • Prior JC, FSH and bone-important physiology or not? Trends in Molecular Medicine. 2007;13: pp 1-3.
  • Prior, JC, Perimenopause lost-reframing the end of menstruation. Journal of Reproductive and Infant Psychology. 2006;  4: 323-335.
  • Richards JB, Joseph L, Schwartzman K, Kreiger N, Tenenhouse A, Goltzman D, The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from CaMOS Research Group. Osteoporosis International. 2006; 17(9):1410-9.
  • Sawka AM, Papaioannou A, Josse RG, Murray TM, Ioannids G, Hanley DA, Prior JC, Thabane L, Papadimitropoulos EA, Gafni A, Pickard L, Anastassiades T, Kirkland S, Adachi JD, and Tenenhouse A, CaMOS Research Group.  What is the Number of Older Canadians Needed to Screen by Measurement of Bone Density to Detect and Undiagnosed Case of Osteoporosis? A Population-Based Study From CaMos. Journal of Clinical Densitometry.  2006; 9(4):413-418.